Research location
Jette
Belgium
Advertisement
Research activity in Jette
BelgiumCureCurrent currently publishes aggregate city-level research activity for this location: 66 trials and 67 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Jette
66 linked trials · page 1 of 2A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)NCT07218146 · 2025-11-30 · 1 site observation
RECRUITING
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesNCT07187531 · 2025-11-25 · 1 site observation
RECRUITING
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyNCT07472517 · 2025-11-07 · 1 site observation
RECRUITING
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerNCT06982521 · 2025-08-26 · 1 site observation
RECRUITING
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesNCT07088068 · 2025-08-06 · 1 site observation
RECRUITING
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA MutationNCT06952803 · 2025-08-06 · 1 site observation
RECRUITING
Biannual Review of Exhaled Air and Trends in Health Evaluation in COPDNCT07045948 · 2025-07-14 · 1 site observation
RECRUITING
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung CancerNCT06868277 · 2025-04-10 · 1 site observation
RECRUITING
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)NCT06878261 · 2025-03-25 · 1 site observation
RECRUITING
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureNCT06742723 · 2025-03-03 · 1 site observation
RECRUITING
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT06417814 · 2024-10-04 · 1 site observation
RECRUITING
A Study of Pitolisant in Patients With Prader-Willi SyndromeNCT06366464 · 2024-05-28 · 1 site observation
RECRUITING
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsNCT06172478 · 2024-02-26 · 1 site observation
RECRUITING
Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 DiabetesNCT05777330 · 2023-08-09 · 1 site observation
RECRUITING
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis StudyNCT04204915 · 2020-03-10 · 1 site observation
RECRUITING
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)NCT07817875 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)NCT05882734 · 2023-09-13 · 1 site observation
COMPLETED
CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple SclerosisNCT05671055 · 2023-01-07 · 1 site observation
COMPLETED
Post Market Clinical Follow-up Study for the Pamira ICD Lead FamilyNCT05621187 · 2022-11-30 · 1 site observation
COMPLETED
Augmented Reality-Assisted Neurosurgical Drain PlacementNCT06571539 · 2021-08-29 · 1 site observation
COMPLETED
Metabotyping of Overweight and Obese ChildrenNCT04632511 · 2021-02-15 · 1 site observation
ACTIVE_NOT_RECRUITING
VR in Diabetic PolyneuropathyNCT04325347 · 2021-01-27 · 1 site observation
COMPLETED
A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell FunctionNCT04628481 · 2021-01-12 · 1 site observation
TERMINATED
A Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseNCT04619420 · 2021-01-06 · 1 site observation
TERMINATED
A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.NCT04899271 · 2020-12-14 · 1 site observation
TERMINATED
The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMsNCT04414280 · 2020-03-12 · 2 site observations
ACTIVE_NOT_RECRUITING
Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RPNCT03899077 · 2019-04-05 · 1 site observation
UNKNOWN
Comparing Continuous With Flash Glucose Monitoring in Adults With Type 1 DiabetesNCT03772600 · 2019-01-29 · 1 site observation
COMPLETED
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerNCT03701334 · 2018-12-07 · 1 site observation
ACTIVE_NOT_RECRUITING
The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has SpreadNCT03659136 · 2018-11-28 · 1 site observation
COMPLETED
Study to Investigate CSL112 in Subjects With Acute Coronary SyndromeNCT03473223 · 2018-03-21 · 1 site observation
COMPLETED
Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid TumorsNCT02988817 · 2016-11-23 · 1 site observation
COMPLETED
Usefulness and Predictive Capacity of ANI and SPI of the Hemodynamic ResponseNCT02608775 · 2016-01-01 · 1 site observation
COMPLETED
"Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients"NCT03591003 · 2015-06-01 · 1 site observation
COMPLETED
Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With SchizophreniaNCT01515423 · 2012-05-01 · 1 site observation
COMPLETED
The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)NCT01490125 · 2011-10-01 · 1 site observation
COMPLETED
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung CancerNCT01348126 · 2011-05-01 · 1 site observation
TERMINATED
External ValidatIon Trial of ASTER TrialNCT01332240 · 2011-04-01 · 1 site observation
UNKNOWN
QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01315249 · 2011-03-01 · 1 site observation
COMPLETED
Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes MellitusNCT01306214 · 2011-02-01 · 1 site observation
COMPLETED
HERO Study: Helping Evaluate Reduction in ObesityNCT00953173 · 2009-12-01 · 1 site observation
COMPLETED
Study of Cabozantinib (XL184) in Adults With Advanced MalignanciesNCT00940225 · 2009-09-01 · 1 site observation
COMPLETED
BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR MutationNCT00949650 · 2009-08-14 · 1 site observation
COMPLETED
A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)NCT00900731 · 2009-06-01 · 1 site observation
COMPLETED
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic PatientsNCT00900146 · 2009-04-01 · 1 site observation
TERMINATED
Exacerbation StudyNCT00845728 · 2009-03-01 · 1 site observation
COMPLETED
Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's DiseaseNCT00722046 · 2008-12-05 · 1 site observation
COMPLETED
Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast CancerNCT00667251 · 2008-10-07 · 1 site observation
COMPLETED
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage TrialNCT00716079 · 2008-09-01 · 1 site observation
COMPLETED
Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC PatientsNCT00730925 · 2008-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.